Evidence map›Paper›PMID 42191083›Full record

ArticleDevelopmental biology2026

Ascl1 promotes OPC specification across species and central nervous system regions and its gliogenic function is regulated by phosphorylation.

Aleezah Balolia, Kimberly A Arena, Anas Shahood, Heran Russom, Luuli N Tran, Caitlin C Winkler, Rebecca O'Rourke, Tou Yia Vue, Charles G Sagerström, Bruce H Appel and 1 more

Abstract read
In one paragraph

Article in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aleezah BaloliaNeuroscience Graduate Program, University of Colorado Anschutz, Aurora, CO, 80045, USA.
Kimberly A ArenaDepartment of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Anas ShahoodGates Summer Internship Program, Gates Institute, University of Colorado Anschutz, Aurora, CO, 80045, USA.
Heran RussomMARC U-STAR Program, University of Colorado Denver, Denver, CO, 80204, USA.
Luuli N TranMolecular Biology Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Caitlin C WinklerDepartment of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Rebecca O'RourkeDepartment of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Tou Yia VueDepartment of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA; New Mexico Alcohol Research Center, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, 87131, USA.
Charles G SagerströmDepartment of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Bruce H AppelDepartment of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA; Program in Pediatric Stem Cell Biology, Children's Hospital Colorado, Aurora, CO, 80045, USA.
Santos J FrancoDepartment of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA; Program in Pediatric Stem Cell Biology, Children's Hospital Colorado, Aurora, CO, 80045, USA. Electronic address: Santos.Franco@CUAnschutz.edu.

Funding

Colorado Clinical and Translational Sciences Institute (CCTSI)UM1TR004399 · NCATS · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS, RONALD J. SOKOL · 2023 to 2026
$30.7M
Mechanisms of Developmental MyelinationR35NS122191 · NINDS · UNIVERSITY OF COLORADO DENVER · PI Bruce H Appel · 2021 to 2026
$5.4M
Predoctoral Training Program in Molecular and Cellular Biology (Supplement: Mentoring in the Research Environment)T32GM136444 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI MICHAEL A MCMURRAY, Rytis Prekeris · 2020 to 2026
$3.7M
Temporal and Spatial Control of Oligodendrocyte Fate SpecificationR01NS124166 · NINDS · UNIVERSITY OF COLORADO DENVER · PI Bruce H Appel, Santos Joe Franco · 2022 to 2026
$2.8M
UC Denver MARC U*STAR Scholars Program SupplementT34GM096958 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI ALLEN, RICHARD M, FLORES, SONIA CASTRO · 2013 to 2022
$2.3M
CTSA Predoctoral T32 at University of Colorado DenverT32TR004367 · NCATS · UNIVERSITY OF COLORADO DENVER · PI Lisa Cicutto · 2023 to 2026
$1.5M
Mechanisms of Oligodendrocyte Fate Specification in the Developing NeocortexR01NS109239 · NINDS · UNIVERSITY OF COLORADO DENVER · PI FRANCO, SANTOS JOE · 2020 to 2023
$1.3M
Investigating the role of Wnt signaling effectors on the neuron-glia switch and OPC specification during development and after injury.F32NS134612 · NINDS · UNIVERSITY OF COLORADO DENVER · PI Kimberly Arena · 2024 to 2026
$223k
The Role of Notch Signaling in Shh-mediated Oligodendrocyte Fate SpecificationF31NS129289 · NINDS · UNIVERSITY OF COLORADO DENVER · PI TRAN, LUULI · 2023 to 2024
$79k
NCATS NIH HHS T32 TR004367NCATS NIH HHS UM1 TR004399NIGMS NIH HHS T32 GM136444NIGMS NIH HHS T34 GM096958NINDS NIH HHS F31 NS129289NINDS NIH HHS F32 NS134612NINDS NIH HHS R01 NS109239NINDS NIH HHS R01 NS124166NINDS NIH HHS R35 NS122191
6 · The paper itself

Abstract

In the developing central nervous system (CNS), neural progenitors first generate neurons before making astrocytes and oligodendrocytes. This transition from neurogenesis to gliogenesis represents a fundamental developmental switch in the vertebrate CNS, but the molecular mechanisms that drive progenitors toward glial fates are not fully understood. In this study, we identify Ascl1 as a conserved regulator of oligodendrocyte lineage specification and demonstrate that this function is regulated by phosphorylation downstream of FGF signaling. We used single-cell sequencing approaches in zebrafish spinal cord and mouse neocortex to show that Ascl1 is expressed in multipotent neural progenitor cells as they transition toward the oligodendrocyte lineage. Moreover, we performed loss of function experiments in zebrafish and mouse and found that Ascl1 promotes oligodendrocyte fate specification across species and CNS regions. We further demonstrated that phosphorylation of ASCL1 is required to direct progenitors toward OPC fate in the mouse neocortex, likely downstream of FGF signaling. Together, our data reveal an FGF-ASCL1 signaling axis that couples extrinsic signaling inputs to intrinsic transcriptional programs governing oligodendrogenesis.

Indexed as

Basic Helix-Loop-Helix ProteinsCentral Nervous SystemOligodendrogliaZebrafish ProteinsAnimalsCell DifferentiationCell LineageFibroblast Growth FactorsGene Expression Regulation, DevelopmentalMiceNeocortexNeural Stem CellsNeurogenesisPhosphorylationSignal TransductionSpinal CordAscl1a protein, zebrafishAscl1 protein, mouseBasic Helix-Loop-Helix ProteinsFibroblast Growth FactorsTranscription FactorsZebrafish ProteinsAscl1Cell fateERKFGFOligodendrocyteOPC

Identifiers

PMID42191083
PMCPMC13302836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.